Eterna Therapeutics company info

What does Eterna Therapeutics do?
Eterna Therapeutics (NASDAQ:ETRN) is a biotechnology firm that focuses on the development and innovation of therapies aimed at treating and potentially curing a variety of diseases. At the heart of their operations is a commitment to research and development, through which they are currently working on several promising projects, including advanced gene editing techniques. These initiatives highlight the company's objective to push the boundaries of medicine and provide groundbreaking solutions for patients worldwide. Eterna Therapeutics is dedicated to advancing healthcare and improving the lives of patients through scientific excellence and innovative treatments.
Eterna Therapeutics company media
Company Snapshot

Is Eterna Therapeutics a public or private company?


How many people does Eterna Therapeutics employ?


What sector is Eterna Therapeutics in?

pie chart
Health Care

Where is the head office for Eterna Therapeutics?

location pin
Head Office
New York, United States

What year was Eterna Therapeutics founded?

founded flag
Year Founded
What does Eterna Therapeutics specialise in?
/Gene Therapy /Rare Diseases /Therapeutic Development /Advanced Biotechnology /Innovative Research /Medical Services

What are the products and/or services of Eterna Therapeutics?

Overview of Eterna Therapeutics offerings
mRNA platform technology aimed at developing vaccines and therapeutics.
Gene editing tools for precision medicine in genetic disorders.
In vivo delivery systems for targeted gene therapy applications.
Collaboration on cancer immunotherapy treatments leveraging mRNA technology.
Partnerships for the development of rare disease treatments using gene therapy.
Research on aging and degenerative disease intervention through novel mRNA applications.

Who is in the executive team of Eterna Therapeutics?

Eterna Therapeutics leadership team
  • Ms. Sandra M. Gurrola
    Ms. Sandra M. Gurrola
    Principal Financial & Accounting Officer and Senior VP of Finance
  • Mr. Sanjeev  Luther
    Mr. Sanjeev Luther
    CEO, President & Director
  • Ms. Dorothy J. Clarke
    Ms. Dorothy J. Clarke
    General Counsel & Director
  • Ms. Megan  Yung
    Ms. Megan Yung
    Chief Strategy Officer